| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.03 |